Editorial
Regenerative Medicine Applied to Treatment of Musculoskeletal Diseases
Medicina regenerativa aplicada al tratamiento de las patologías musculoesqueléticas
José Ramón Lamas López
Servicio de Reumatología, Instituto de Investigación Sanitaria San Carlos (IdISSC), Hospital Clínico San Carlos, Madrid, Spain
Read
6387
Timeswas read the article
2088
Total PDF
4299
Total HTML
Share statistics
array:23 [ "pii" => "S2173574314000811" "issn" => "21735743" "doi" => "10.1016/j.reumae.2014.04.001" "estado" => "S300" "fechaPublicacion" => "2014-05-01" "aid" => "678" "copyright" => "Elsevier España, S.L.. All rights reserved" "copyrightAnyo" => "2014" "documento" => "article" "crossmark" => 0 "subdocumento" => "sco" "cita" => "Reumatol Clin. 2014;10:139-40" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2079 "formatos" => array:3 [ "EPUB" => 52 "HTML" => 1625 "PDF" => 402 ] ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S1699258X14000862" "issn" => "1699258X" "doi" => "10.1016/j.reuma.2014.04.001" "estado" => "S300" "fechaPublicacion" => "2014-05-01" "aid" => "678" "copyright" => "Elsevier España, S.L." "documento" => "article" "crossmark" => 0 "subdocumento" => "sco" "cita" => "Reumatol Clin. 2014;10:139-40" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 10094 "formatos" => array:3 [ "EPUB" => 170 "HTML" => 8252 "PDF" => 1672 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>" "titulo" => "Medicina regenerativa aplicada al tratamiento de las patologías musculoesqueléticas" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "139" "paginaFinal" => "140" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Regenerative medicine applied to treatment of musculoskeletal diseases" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "José Ramón Lamas López" "autores" => array:1 [ 0 => array:2 [ "nombre" => "José Ramón" "apellidos" => "Lamas López" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2173574314000811" "doi" => "10.1016/j.reumae.2014.04.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574314000811?idApp=UINPBA00004M" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X14000862?idApp=UINPBA00004M" "url" => "/1699258X/0000001000000003/v1_201405040016/S1699258X14000862/v1_201405040016/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2173574314000574" "issn" => "21735743" "doi" => "10.1016/j.reumae.2014.01.005" "estado" => "S300" "fechaPublicacion" => "2014-05-01" "aid" => "647" "copyright" => "Elsevier España, S.L." "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Reumatol Clin. 2014;10:141-6" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2615 "formatos" => array:3 [ "EPUB" => 60 "HTML" => 2117 "PDF" => 438 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>" "titulo" => "A Report of 4 Years of Experience of a Multidisciplinary Unit of Psoriasis and Psoriatic Arthritis" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "141" "paginaFinal" => "146" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Experiencia de 4 años de funcionamiento de una unidad multidisciplinar de psoriasis y artritis psoriásica" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0020" "etiqueta" => "Fig. 4" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr4.jpeg" "Alto" => 1668 "Ancho" => 1506 "Tamanyo" => 98571 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">Results of diagnostic and therapeutic referral to the Derma Psoriasis Rheumatism (PSORD) multidisciplinary unit.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Jesus Luelmo, Jordi Gratacós, Mireia Moreno Martínez-Losa, Miguel Ribera, Jorge Romaní, Juan Calvet, Lorena Leal, Marta Larrosa" "autores" => array:8 [ 0 => array:2 [ "nombre" => "Jesus" "apellidos" => "Luelmo" ] 1 => array:2 [ "nombre" => "Jordi" "apellidos" => "Gratacós" ] 2 => array:2 [ "nombre" => "Mireia" "apellidos" => "Moreno Martínez-Losa" ] 3 => array:2 [ "nombre" => "Miguel" "apellidos" => "Ribera" ] 4 => array:2 [ "nombre" => "Jorge" "apellidos" => "Romaní" ] 5 => array:2 [ "nombre" => "Juan" "apellidos" => "Calvet" ] 6 => array:2 [ "nombre" => "Lorena" "apellidos" => "Leal" ] 7 => array:2 [ "nombre" => "Marta" "apellidos" => "Larrosa" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1699258X14000278" "doi" => "10.1016/j.reuma.2014.01.004" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X14000278?idApp=UINPBA00004M" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574314000574?idApp=UINPBA00004M" "url" => "/21735743/0000001000000003/v2_201406190029/S2173574314000574/v2_201406190029/en/main.assets" ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>" "titulo" => "Regenerative Medicine Applied to Treatment of Musculoskeletal Diseases" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "139" "paginaFinal" => "140" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "José Ramón Lamas López" "autores" => array:1 [ 0 => array:3 [ "nombre" => "José Ramón" "apellidos" => "Lamas López" "email" => array:1 [ 0 => "jrlamas@gmail.com" ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Servicio de Reumatología, Instituto de Investigación Sanitaria San Carlos (IdISSC), Hospital Clínico San Carlos, Madrid, Spain" "identificador" => "aff0005" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Medicina regenerativa aplicada al tratamiento de las patologías musculoesqueléticas" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Musculoskeletal diseases encompass a wide spectrum of diseases affecting different connective tissues of the skeletal system, including bones, cartilage, muscles, tendons and ligaments. Often, the symptoms associated with local or systemic inflammatory processes occur both acutely and chronically. Overall, they are very prevalent, and their increasing incidence and socioeconomic impact are unquestionable.<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1,2</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">Skeletal muscle tissue structures are highly adapted to their function, a feature that limits their ability to structurally and functionally be restored after suffering an injury. Arthritis and joint lesions are the paradigm of musculoskeletal injury located on a complex structure, the joint, on which several skeletal tissues converge. However, the nature of musculoskeletal disease is complex and poorly understood. Due to the lack of knowledge regarding the origin of many of these diseases the current pharmacological treatment options are limited, in most cases, to controlling their symptoms rather than curing and/or preventing disease. In this context, the development of new therapies that improve existing treatments is a priority. In recent years, the most promising hopes have focused on the development and application of different techniques of regenerative medicine in order to reverse, at different levels, the damage caused by the disease.</p><p id="par0015" class="elsevierStylePara elsevierViewall">Conceptually, although the term “regenerative medicine” includes the creation of artificial organs and their subsequent implantation, its most realistic definition refers to the set of processes used to repair or replace tissue or organ function by stimulating and inducing their own self-regeneration. Schematically, this discipline encompasses two therapeutic strategies: those based on the use of living cells or cell-based therapies and those based on tissue engineering <span class="elsevierStyleItalic">using different scaffolds</span> and matrices with biocompatible materials, alone or in combination, to provide support and facilitate the repair of tissue damage.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> Among cell therapies, one may differentiate 2 types of products based on mature cells, grafts or implants, and those using stem or progenitor cells.</p><p id="par0020" class="elsevierStylePara elsevierViewall">The application of different regenerative techniques has enabled the development of different basic, preclinical and clinical studies with encouraging results for the treatment of various diseases, including those of musculoskeletal origin.<a class="elsevierStyleCrossRefs" href="#bib0020"><span class="elsevierStyleSup">4,5</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">The first strategies to repair damage to the bone or cartilage tissue consisted of transplantation or implantation of autografts to provide a supply of cells to support an influx of osteo or chondroinducting factors. However, these methods have limitations in their bioavailability and the size of the lesion to be repaired. Alternatives such as allogeneic and/or xenogeneic transplants need further analysis regarding the risk of rejection, disease transmission and/or teratogenicity.</p><p id="par0030" class="elsevierStylePara elsevierViewall">The therapeutic potential of each strategy depends on the nature of damage to repair. Its widespread application is still subject to the resolution of technical and biological aspects; however, advances in this field are growing, in particular those related to cellular therapies applied to musculoskeletal diseases, one of the most promising fields for medium-term treatments.<a class="elsevierStyleCrossRefs" href="#bib0030"><span class="elsevierStyleSup">6–8</span></a></p><p id="par9001" class="elsevierStylePara elsevierViewall">To understand the fundamentals and the potential of cell therapies in musculoskeletal diseases we can draw analogies with the composition of a classic drug. Not surprisingly, and bridging gaps, cellular therapies are considered drugs, and as such must meet all stages of drug development, including their <span class="elsevierStyleItalic">adequate</span> manufacturing <span class="elsevierStyleItalic">practices and</span> conditions (GMP). By definition, the principal component or ‘active ingredient’ of cell therapy is the cell itself, while the “carrier” would be represented by growth factors and/or biomaterials that facilitate structural integration or differentiation of cells. The cell component may be composed of mature or undifferentiated cells. Thus, chondrocytes or cartilage explants developed for the treatment of chondral defects are an example of the first type. However, the use of differentiated cells has not satisfactorily met expectations. Currently, attention has focused on the progenitor cells with improved biological properties and superior plasticity to those already differentiated.<a class="elsevierStyleCrossRefs" href="#bib0045"><span class="elsevierStyleSup">9,10</span></a></p><p id="par0035" class="elsevierStylePara elsevierViewall">A stem or progenitor cell is defined in terms of its ability to divide asymmetrically, i.e. self renewing itself while maintaining its undifferentiated state, or divide and differentiate into other cell types. Broadly speaking, and depending on their origin, stem cells are grouped into 2 categories: embryonic stem cells (ESC) and adult stem cells (ASC). This classification carries other intrinsic differentiation potential. Thus, ESC, deriving from the embryonic blastocyst can differentiate into cells belonging to any of the 3 embryonic layers: ectoderm, endoderm and mesoderm (from which skeletal tissues originate).This totipotency, however, can cause problems when undergoing therapeutic application, arising from their high proliferation capacity and the possibility of ectopic teratoma formation. Thus, the most reasonable approach, from the point of view of their therapeutic application, is to use cells with limited differentiation potential, specific to an embryonic single layer lineage.</p><p id="par0040" class="elsevierStylePara elsevierViewall">Experimentally it is possible to induce reprogramming of adult cells to a pluripotent immature state, called <span class="elsevierStyleItalic">induced pluripotent stem cells</span> (iPSC), but its application is still under investigation. While scientific advances to avoid the risk arising from the application of the previous cell types have been made, the best current option is the use of natural skeletal progenitor cells, <span class="elsevierStyleItalic">mesenchymal stem cells</span> (MSC).</p><p id="par0045" class="elsevierStylePara elsevierViewall">MSCs are mesodermal embryonic stem cells from which adult connective tissues develop. Therefore, they constitute progenitor cells of other specialized cells such as chondrocytes, osteoblasts, adipocytes, tenocytes, myoblasts, among others. They retain their self-renewal capacity, which facilitates their <span class="elsevierStyleItalic">in vitro</span> expansion. In addition to differentiating into different lineages, if subjected to an appropriate postimplantation stimulus in vitro or in vivo, they have immunomodulatory properties<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">11</span></a> Originally, they were described in the bone marrow stroma. They are currently known to be virtually ubiquitous, although adipose tissue along with bone marrow are the most common sources of MSC. Their frequency in tissues decreases with age,<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">12</span></a> and more importantly, the tissue of origin seem to confer particular characteristics that can alter their immunomodulatory properties.<a class="elsevierStyleCrossRefs" href="#bib0065"><span class="elsevierStyleSup">13,14</span></a> This variability may be related to the fact that MSCs are actually a heterogeneous population of cells. In fact, due to the absence of a single common tag, the definition of an MSC is performed according to the performance of three minimum criteria: their ability to adhere to culture medium, the presence of various cell surface markers and the absence hematopoietic lineage markers, and finally, their in vitro ability to commit to osteogenic, chondrogenic and adipogenic lineages, generally determined by histochemical staining. Given the relative laxity of the selection criteria, one of the challenges lies in the unambiguous characterization of MSC as a single entity, a task that has not yet been achieved.</p><p id="par0050" class="elsevierStylePara elsevierViewall">The immunomodulatory functions of MSC, one of the aspects of their therapeutic potential, are gaining more importance and has already been applied in different pathologies. The study of the immunomodulatory potential of MSCs was described originally by studying their effect on regulatory T cells, such as ras initiation and mediators of transplant rejection. Numerous evidences have shown that under inflammatory conditions, MSC may inhibit T cell effector responses or increase Treg-mediated regulatory function. Furthermore, they can also exert various effects on other immune cells. Thus, MSC inhibit the maturation of dendritic cells preventing their migration to the lymph nodes and their antigen presenting function; they modulate macrophages and NK cells, and suppress the proliferation and terminal differentiation of B<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">15</span></a> cells. The mechanisms through which they carry out these functions are both dependent on cell contact and through secretion of soluble factors.<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">16</span></a></p><p id="par0055" class="elsevierStylePara elsevierViewall">Despite decades of research, safety issues have hindered, for years, regenerative medicine's potential to transform from a more generalized treatment to its application in musculoskeletal diseases. However, the bifunctional capacity of MSC to regenerate and regulate immune responses has stimulated a large number of clinical trials for different therapeutic indications which go beyond the mere provision of progenitor intended to replace lost cells or rebuild damaged tissues. At present the establishment of biobanks is a reality and the use of different products and biomaterials are part of many current clinical trials. Future efforts have to exactly determine aspects of cell biology that remain unresolved, including the pathways that determine the commitment to a particular lineage and the most appropriate therapeutic application.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Lamas López JR. Medicina regenerativa aplicada al tratamiento de las patologías musculoesqueléticas. Reumatol Clin. 2014;10:139–140.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:16 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C.J. Murray" 1 => "T. Vos" 2 => "R. Lozano" 3 => "M. Naghavi" 4 => "A.D. Flaxman" 5 => "C. Michaud" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(12)61689-4" "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "2012" "volumen" => "380" "paginaInicial" => "2197" "paginaFinal" => "2223" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23245608" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cost of temporary work disability due to musculoskeletal diseases in Spain" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "P. Lazaro" 1 => "E. Parody" 2 => "R. Garcia-Vicuna" 3 => "G. Gabriele" 4 => "J.A. Jover" 5 => "J. Sevilla" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.reuma.2013.07.001" "Revista" => array:6 [ "tituloSerie" => "Reumatol Clin" "fecha" => "2014" "volumen" => "10" "paginaInicial" => "109" "paginaFinal" => "112" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24079952" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The use of scaffolds in musculoskeletal tissue engineering" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "F. Henson" 1 => "A. Getgood" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2174/1874325001105010261" "Revista" => array:7 [ "tituloSerie" => "Open Orthop J" "fecha" => "2011" "volumen" => "5" "numero" => "Suppl. 2" "paginaInicial" => "261" "paginaFinal" => "266" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21886690" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "A. Giordano" 1 => "U. Galderisi" 2 => "I.R. Marino" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/jcp.20959" "Revista" => array:6 [ "tituloSerie" => "J Cell Physiol" "fecha" => "2007" "volumen" => "211" "paginaInicial" => "27" "paginaFinal" => "35" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17226788" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pluripotent stem cells in regenerative medicine: challenges and recent progress" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "V. Tabar" 1 => "L. Studer" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/nrg3563" "Revista" => array:6 [ "tituloSerie" => "Nat Rev Genet" "fecha" => "2014" "volumen" => "15" "paginaInicial" => "82" "paginaFinal" => "92" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24434846" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Stem cell therapy for osteoporosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "B. Antebi" 1 => "G. Pelled" 2 => "D. Gazit" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s11914-013-0184-x" "Revista" => array:6 [ "tituloSerie" => "Curr Osteoporos Rep" "fecha" => "2014" "volumen" => "12" "paginaInicial" => "41" "paginaFinal" => "47" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24407712" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mesenchymal stem cells for cartilage engineering" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "C. Huselstein" 1 => "Y. Li" 2 => "X. He" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3233/BME-2012-0691" "Revista" => array:6 [ "tituloSerie" => "Biomed Mater Eng" "fecha" => "2012" "volumen" => "22" "paginaInicial" => "69" "paginaFinal" => "80" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22766704" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Musculoskeletal tissue engineering by endogenous stem/progenitor cells" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "H. Nie" 1 => "C.H. Lee" 2 => "J. Tan" 3 => "C. Lu" 4 => "A. Mendelson" 5 => "M. Chen" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00441-012-1339-2" "Revista" => array:6 [ "tituloSerie" => "Cell Tissue Res" "fecha" => "2012" "volumen" => "347" "paginaInicial" => "665" "paginaFinal" => "676" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22382390" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment of joint cartilage lesions with cell therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "I.M. Fuentes-Boquete" 1 => "M.C. Arufe Gonda" 2 => "S.M. Diaz Prado" 3 => "T. Hermida Gomez" 4 => "F.J. de Toro Santos" 5 => "F.J. Blanco Garcia" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S1699-258X(07)73658-6" "Revista" => array:6 [ "tituloSerie" => "Reumatol Clin" "fecha" => "2007" "volumen" => "3" "paginaInicial" => "S63" "paginaFinal" => "S69" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21794485" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Tissue engineering and osteoarthritis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "C. Ibarra" 1 => "D. Garciadiego" 2 => "V. Martinez" 3 => "C. Velasquillo" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S1699-258X(07)73650-1" "Revista" => array:6 [ "tituloSerie" => "Reumatol Clin" "fecha" => "2007" "volumen" => "3" "paginaInicial" => "S19" "paginaFinal" => "S22" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21794475" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0055" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mesenchymal stem cell and regenerative medicine: regeneration versus immunomodulatory challenges" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "S. Law" 1 => "S. Chaudhuri" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Am J Stem Cells" "fecha" => "2013" "volumen" => "2" "paginaInicial" => "22" "paginaFinal" => "38" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23671814" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0060" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mesenchymal stem cells aging and regenerative medicine" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "C. Raggi" 1 => "A.C. Berardi" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Muscles Ligaments Tendons J" "fecha" => "2012" "volumen" => "2" "paginaInicial" => "239" "paginaFinal" => "242" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23738303" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0065" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of mesenchymal stem cells from different tissues to suppress T-cell activation" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "K.A. Keyser" 1 => "K.E. Beagles" 2 => "H.P. Kiem" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Cell Transplant" "fecha" => "2007" "volumen" => "16" "paginaInicial" => "555" "paginaFinal" => "562" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17708345" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0070" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "S.M. Melief" 1 => "J.J. Zwaginga" 2 => "W.E. Fibbe" 3 => "H. Roelofs" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.5966/sctm.2012-0184" "Revista" => array:6 [ "tituloSerie" => "Stem Cells Transl Med" "fecha" => "2013" "volumen" => "2" "paginaInicial" => "455" "paginaFinal" => "463" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23694810" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0075" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immunomodulatory effect of mesenchymal stem cells on B cells" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "M. Franquesa" 1 => "M.J. Hoogduijn" 2 => "O. Bestard" 3 => "J.M. Grinyo" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3389/fimmu.2012.00212" "Revista" => array:5 [ "tituloSerie" => "Front Immunol" "fecha" => "2012" "volumen" => "3" "paginaInicial" => "212" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22833744" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0080" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "T. Yi" 1 => "S.U. Song" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s12272-012-0202-z" "Revista" => array:6 [ "tituloSerie" => "Arch Pharm Res" "fecha" => "2012" "volumen" => "35" "paginaInicial" => "213" "paginaFinal" => "221" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22370776" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/21735743/0000001000000003/v2_201406190029/S2173574314000811/v2_201406190029/en/main.assets" "Apartado" => array:4 [ "identificador" => "17335" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Editorial" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/21735743/0000001000000003/v2_201406190029/S2173574314000811/v2_201406190029/en/main.pdf?idApp=UINPBA00004M&text.app=https://reumatologiaclinica.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574314000811?idApp=UINPBA00004M" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 5 | 2 | 7 |
| 2024 October | 51 | 32 | 83 |
| 2024 September | 49 | 17 | 66 |
| 2024 August | 70 | 30 | 100 |
| 2024 July | 70 | 38 | 108 |
| 2024 June | 55 | 28 | 83 |
| 2024 May | 79 | 33 | 112 |
| 2024 April | 56 | 25 | 81 |
| 2024 March | 47 | 32 | 79 |
| 2024 February | 41 | 29 | 70 |
| 2024 January | 42 | 22 | 64 |
| 2023 December | 32 | 30 | 62 |
| 2023 November | 46 | 31 | 77 |
| 2023 October | 51 | 32 | 83 |
| 2023 September | 84 | 38 | 122 |
| 2023 August | 32 | 24 | 56 |
| 2023 July | 42 | 30 | 72 |
| 2023 June | 43 | 35 | 78 |
| 2023 May | 46 | 29 | 75 |
| 2023 April | 26 | 15 | 41 |
| 2023 March | 49 | 32 | 81 |
| 2023 February | 41 | 23 | 64 |
| 2023 January | 47 | 23 | 70 |
| 2022 December | 46 | 36 | 82 |
| 2022 November | 51 | 22 | 73 |
| 2022 October | 48 | 33 | 81 |
| 2022 September | 40 | 29 | 69 |
| 2022 August | 38 | 35 | 73 |
| 2022 July | 34 | 45 | 79 |
| 2022 June | 42 | 32 | 74 |
| 2022 May | 43 | 42 | 85 |
| 2022 April | 68 | 59 | 127 |
| 2022 March | 52 | 42 | 94 |
| 2022 February | 52 | 31 | 83 |
| 2022 January | 60 | 48 | 108 |
| 2021 December | 48 | 36 | 84 |
| 2021 November | 44 | 45 | 89 |
| 2021 October | 47 | 53 | 100 |
| 2021 September | 48 | 36 | 84 |
| 2021 August | 45 | 38 | 83 |
| 2021 July | 45 | 31 | 76 |
| 2021 June | 49 | 41 | 90 |
| 2021 May | 50 | 26 | 76 |
| 2021 April | 80 | 68 | 148 |
| 2021 March | 92 | 24 | 116 |
| 2021 February | 54 | 18 | 72 |
| 2021 January | 36 | 17 | 53 |
| 2020 December | 47 | 14 | 61 |
| 2020 November | 38 | 17 | 55 |
| 2020 October | 16 | 17 | 33 |
| 2020 September | 80 | 27 | 107 |
| 2020 August | 28 | 21 | 49 |
| 2020 July | 21 | 20 | 41 |
| 2020 June | 37 | 25 | 62 |
| 2020 May | 25 | 7 | 32 |
| 2020 April | 52 | 12 | 64 |
| 2020 March | 14 | 9 | 23 |
| 2020 February | 1 | 0 | 1 |
| 2018 May | 4 | 0 | 4 |
| 2018 April | 34 | 11 | 45 |
| 2018 March | 35 | 7 | 42 |
| 2018 February | 17 | 7 | 24 |
| 2018 January | 19 | 6 | 25 |
| 2017 December | 24 | 6 | 30 |
| 2017 November | 25 | 9 | 34 |
| 2017 October | 32 | 12 | 44 |
| 2017 September | 33 | 7 | 40 |
| 2017 August | 43 | 16 | 59 |
| 2017 July | 41 | 13 | 54 |
| 2017 June | 69 | 11 | 80 |
| 2017 May | 68 | 12 | 80 |
| 2017 April | 63 | 12 | 75 |
| 2017 March | 51 | 12 | 63 |
| 2017 February | 30 | 10 | 40 |
| 2017 January | 32 | 10 | 42 |
| 2016 December | 64 | 14 | 78 |
| 2016 November | 61 | 13 | 74 |
| 2016 October | 73 | 12 | 85 |
| 2016 September | 77 | 7 | 84 |
| 2016 August | 49 | 3 | 52 |
| 2016 July | 40 | 11 | 51 |
| 2016 April | 1 | 0 | 1 |
| 2015 December | 2 | 0 | 2 |
| 2015 September | 1 | 0 | 1 |
| 2015 August | 3 | 0 | 3 |
| 2015 July | 17 | 6 | 23 |
| 2015 June | 25 | 6 | 31 |
| 2015 May | 60 | 11 | 71 |
| 2015 April | 38 | 16 | 54 |
| 2015 March | 24 | 6 | 30 |
| 2015 February | 40 | 6 | 46 |
| 2015 January | 58 | 13 | 71 |
| 2014 December | 41 | 14 | 55 |
| 2014 November | 40 | 12 | 52 |
| 2014 October | 30 | 11 | 41 |
| 2014 September | 26 | 17 | 43 |
| 2014 August | 26 | 8 | 34 |
| 2014 July | 38 | 15 | 53 |
| 2014 June | 89 | 27 | 116 |
| 2014 May | 81 | 13 | 94 |
Show all
